Andrew Zambanini

Effects of the Direct Lipoprotein-Associated Phospholipase A ₂ Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

Patrick W. Serruys, Héctor M. García‐García, Paweł Buszman et al. · Circulation · 2008 · 503 citations · Full text

Injection related anxiety in insulin-treated diabetes

Andrew Zambanini, Roger Newson, M.N. Maisey et al. · Diabetes Research and Clinical Practice · 1999 · 285 citations

Diabetes Management, Psychiatry, Insulin Management +4

Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy

Andrew S.P. Sharp, Robyn J. Tapp, Simon Thom et al. · European Heart Journal · 2009 · 207 citations · Full text

A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure

Henry J. Dargie, Per Hildebrandt, Günter A.J. Riegger et al. · Journal of the American College of Cardiology · 2007 · 204 citations

Heart Failure, Cardiovascular Disease, Diabetes +7

Curvature and tortuosity of the superficial femoral artery: a possible risk factor for peripheral arterial disease

Nigel B. Wood, Sarah Zhao, Andrew Zambanini et al. · Journal of Applied Physiology · 2006 · 145 citations